Citation Impact

Citing Papers

Histone H3.3K27M Represses p16 to Accelerate Gliomagenesis in a Murine Model of DIPG
2017
dCas9 fusion to computer-designed PRC2 inhibitor reveals functional TATA box in distal promoter region
2022 StandoutNobel
Texture analysis on MR images helps predicting non-response to NAC in breast cancer
2015
CBTRUS Statistical Report: Primary brain and other central nervous system tumors diagnosed in the United States in 2010–2014
2017 Standout
Role of Oncogenes and Tumor-suppressor Genes in Carcinogenesis: A Review
2020 Standout
Genomic Insights into Diffuse Intrinsic Pontine Glioma
2017
The 2016 World Health Organization classification of tumours of the central nervous system
2018
Advances in the molecular genetics of gliomas — implications for classification and therapy
2016
Promises and challenges for the implementation of computational medical imaging (radiomics) in oncology
2017 Standout
Diffuse high-grade gliomas with H3 K27M mutations carry a dismal prognosis independent of tumor location
2017
Methylation array profiling of adult brain tumours: diagnostic outcomes in a large, single centre
2019
Management of glioblastoma: State of the art and future directions
2020 Standout
CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2011–2015
2018 Standout
The 2021 WHO Classification of Tumors of the Central Nervous System: a summary
2021 Standout
CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2014–2018
2021 Standout
CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2012–2016
2019 Standout
Modeling and Targeting MYC Genes in Childhood Brain Tumors
2017

Works of Raphaël Calmon being referenced

Histone H3F3A and HIST1H3B K27M mutations define two subgroups of diffuse intrinsic pontine gliomas with different prognosis and phenotypes
2015
Accuracy of perfusion MRI with high spatial but low temporal resolution to assess invasive breast cancer response to neoadjuvant chemotherapy: a retrospective study
2011
Rankless by CCL
2026